Nadia Ghazali: Canadian Lung Cancer Conference 2026 – Debating Tarlatamab as Maintenance Treatment in Extensive-Stage SCLC
Nadia Ghazali/LinkedIn

Nadia Ghazali: Canadian Lung Cancer Conference 2026 – Debating Tarlatamab as Maintenance Treatment in Extensive-Stage SCLC

Nadia Ghazali, Medical Oncologist at Cross Cancer Institute, shared a post on LinkedIn:

“What a meeting here in Vancouver. Microphone dropping performance by the great Geoff Liu, debating Tarlatamab as maintenance treatment in extensive-stage small cell lung cancer. Speakers from all over the world. Amazing butter chicken and closing dinner catered by Miku.

And most importantly catching up with my colleagues and friends from all over Canada. Priceless.

Canadian Lung Cancer Conference 2026.

Nadia Ghazali: Canadian Lung Cancer Conference 2026 – Debating Tarlatamab as Maintenance Treatment in Extensive-Stage SCLC

More posts featuring Nadia Ghazali.